ubiquitin C-terminal hydrolase L1
Last updated 17 Jul 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The UCHL1 gene provides instructions for making an enzyme called ubiquitin carboxyl-terminal esterase L1. This enzyme is found in nerve cells throughout the brain. Ubiquitin carboxyl-terminal esterase L1 is probably involved in the cell machinery that breaks down (degrades) unneeded proteins. In cells, damaged or excess proteins are tagged with molecules called ubiquitin. Ubiquitin serves as a signal to move these unneeded proteins into specialized structures known as proteasomes, where the proteins are degraded. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins.
Video picks for GenesVideo library
Normal function
The UCHL1 gene provides instructions for making an enzyme called ubiquitin carboxyl-terminal esterase L1. This enzyme is found in nerve cells throughout the brain. Ubiquitin carboxyl-terminal esterase L1 is probably involved in the cell machinery that breaks down (degrades) unneeded proteins. In cells, damaged or excess proteins are tagged with molecules called ubiquitin. Ubiquitin serves as a signal to move these unneeded proteins into specialized structures known as proteasomes, where the proteins are degraded. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins.
Although the exact function of ubiquitin carboxyl-terminal esterase L1 is not fully understood, it appears to have two types of enzyme activity. One of these, called hydrolase activity, removes and recycles ubiquitin molecules from degraded proteins. This recycling step is important to sustain the degradation process. The other enzyme function, known as ligase activity, links together ubiquitin molecules for use in tagging proteins for disposal.
Conditions referring to this gene or chromosome
Other names
MSY1
neuron cytoplastic protein 9.5
PARK5
PGP9.5
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
ubiquitin thiolesterase
UBL1
UCHL-1
UCHL1_HUMAN
Patient picks for Genes

Infections
Clostridioides difficile
Infection with Clostridioides difficile (sometimes just called 'C. diff') most commonly occurs in people who have recently had a course of antibiotics and are in hospital. Symptoms can range from mild diarrhoea to a life-threatening inflammation of the bowel. No treatment may be needed in mild cases except drinking plenty of fluids. However, treatment with specific antibiotics is needed in more severe cases.
by Dr Hayley Willacy, FRCGP

Pregnancy
Caesarean section
A caesarean section (C-section) may be planned (elective caesarean section) or unplanned (including emergency or crash caesarean sections).
by Dr Colin Tidy, MRCGP

Medicine
Ascorbic acid tablets
Ascorbic acid is another name for vitamin C. One dose a day of 25-75 mg is sufficient to prevent vitamin C deficiency. Higher doses are sometimes prescribed by doctors to treat a condition called scurvy (although this occurs only rarely in the UK). Some ascorbic acid tablets should be chewed before they are swallowed and others need to be dissolved in water first. Check the label on the container and follow the directions given.
by Michael Stewart, MRPharmS

Medicine
Clindamycin capsules for infection
Take your doses spaced out evenly throughout the day, ideally every six hours. Swallow the capsules with a full glass of water. You can take clindamycin before or after food. The most common side effects of clindamycin are feeling sick (nausea), being sick (vomiting), and tummy (stomach) discomfort. If you develop diarrhoea while you are taking clindamycin, you must contact your doctor for advice before you take any more doses.
by Michael Stewart, MRPharmS

Mental health
Eat Your Way to Calm - Foods That Fight Stress and Anxiety
Discover how incorporating magnesium-rich greens, zinc-packed foods, vitamin C sources, omega-3 fatty acids, fiber, and probiotics into your diet can support mental wellbeing and help manage stress and anxiety.

Senior health
How to cope with a terminal illness at Christmas
Christmas can be very distressing when you have a terminal illness. When festive cheer is all around but you know you are dying and this might be your last Christmas, this time of year can be unsettling. Likewise, it can be hard for loved ones to know how to act when they don't know how long they have left with a family member.
by Emily Jane Bashforth
Related patient information and medicines

Patient information leaflet
Neuroblastoma
Neuroblastoma is a cancer affecting developing nerve cells. Neuroblastoma is a rare cancer and most often occurs in children under 5 years old. Neuroblastoma often starts in the tummy (abdomen) but can spread to other parts of the body, especially bones, liver a... Systems used to find the stage of the neuroblastoma often include CT scans. The.

Patient information leaflet
Bile acid diarrhoea
Bile acid diarrhoea is common, especially in people who are thought to have irritable bowel syndrome. Bile acid diarrhoea may be caused by a problem with the bowel. Much more often there is no medical problem caus... Increased levels indicate bile acid diarrhoea. The National Institute for Health and Care Excellence (NICE) issued guidance in 2021.

Patient information leaflet
Respiratory failure
Asthma Asthma. Pneumothorax Pneumothorax. Pulmonary embolism Pulmonary embolism. Pulmonary hypertension (high blood pressure in the blood vessels that supply the lungs). Cyanotic congenital heart disease Congenital heart disease. Bronchiectasis Bronchiectasis. Acute respiratory distress syndrome (ARDS): a life-threatening condition in which the.

Patient information leaflet
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a long-term condition of the lungs where the flow of air to the lungs is obstructed. Symptoms include cough and breathlessness. Inhalers are commonly used to ease symptoms. Other treatments such as steroids, antibiotics, oxygen, and mucus-thinning (mucolytic) medicines are sometimes prescribed in.

Patient information leaflet
Heart failure
It means that your heart is not functioning as well as it should. Heart failure can be caused by many different conditions. Symptoms include fluid retention, breathlessness and tiredness. Medication can usually ease symptoms and can often improve the outlook. For more information on heart failure, go to.

Patient information leaflet
Clostridioides difficile
Infection with Clostridioides difficile (sometimes just called 'C. diff') most commonly occurs in people who have recently had a course of antibiotics and are in hospital. Symptoms can range from mild diarrhoea to a life-threatening inflammation of the bowel. No treatment may be needed in mild cases except drinking plenty of fluids. It lives.
Further reading and references
- ubiquitin C-terminal hydrolase L1; MedlinePlus, National Library of Medicine.
- Facheris M, Strain KJ, Lesnick TG, de Andrade M, Bower JH, Ahlskog JE, Cunningham JM, Lincoln S, Farrer MJ, Rocca WA, Maraganore DM. UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study. Neurosci Lett. 2005 Jun 10-17;381(1-2):131-4. doi: 10.1016/j.neulet.2005.02.008. Epub 2005 Feb 25.
- Healy DG, Abou-Sleiman PM, Casas JP, Ahmadi KR, Lynch T, Gandhi S, Muqit MM, Foltynie T, Barker R, Bhatia KP, Quinn NP, Lees AJ, Gibson JM, Holton JL, Revesz T, Goldstein DB, Wood NW. UCHL-1 is not a Parkinson's disease susceptibility gene. Ann Neurol. 2006 Apr;59(4):627-33. doi: 10.1002/ana.20757.
- Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. Eur J Neurol. 2008 Feb;15(2):134-9. doi: 10.1111/j.1468-1331.2007.02012.x. Epub 2007 Dec 18.
- Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell. 2002 Oct 18;111(2):209-18. doi: 10.1016/s0092-8674(02)01012-7.
- Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Kruger R, Hattori N, Mellick GD, Quattrone A, Satoh J, Toda T, Wang J, Ioannidis JP, de Andrade M, Rocca WA; UCHL1 Global Genetics Consortium. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol. 2004 Apr;55(4):512-21. doi: 10.1002/ana.20017.
- Ragland M, Hutter C, Zabetian C, Edwards K. Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis. Am J Epidemiol. 2009 Dec 1;170(11):1344-57. doi: 10.1093/aje/kwp288. Epub 2009 Oct 28.
- Tan EK, Puong KY, Fook-Chong S, Chua E, Shen H, Yuen Y, Pavanni R, Wong MC, Puvan K, Zhao Y. Case-control study of UCHL1 S18Y variant in Parkinson's disease. Mov Disord. 2006 Oct;21(10):1765-8. doi: 10.1002/mds.21064.
- Wintermeyer P, Kruger R, Kuhn W, Muller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schols L, Epplen JT, Riess O. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport. 2000 Jul 14;11(10):2079-82. doi: 10.1097/00001756-200007140-00004.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

